Pancreatic carcinoma (PDAC) is one of the most difficult malignancies to treat. Individual patient and tumor factors need to be taken into account to provide an optimal, individualized approach. In this article, biomarkers for pancreatic cancer prognosis and some can be used to guide treatment decisions.